PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Sucrose
ساکارز، سوکروز، شکر
1Nonproprietary names
- BPSucrose
- JPSucrose
- Ph. Eur.Sucrose
- USP–NFSucrose
2Synonyms and trade names
beet sugar; cane sugar; α-D-glucopyranosyl-β-D-fructofuranoside; refined sugar; saccharose; saccharum; sugar
3Chemical name and CAS Registry Number
β-D-Fructofuranosyl-α-D-glucopyranoside · [57-50-1]
UNII C151H8M554 · PubChem CID 5988
4Empirical formula and molecular weight
C12H22O11 · 342.30
5Functional category
Sweetening agent
Typical concentrations: up to 67% in syrups · Dosage forms: Liquid, Solid
6Applications in pharmaceutical formulation
Used as a sweetener and viscosity-increasing agent in oral liquids, as a binder and filler in tablets (especially chewable tablets and lozenges), as the main component of sugar coatings, and as a stabiliser and lyoprotectant in freeze-dried and liquid biological products. Typical concentrations: syrups about 67% w/w (close to saturation, which makes them self-preserving); sugar-coating syrups 50–67% w/w; tablet binder 2–20% w/w as a dry powder, or as a 50–67% w/w syrup in wet granulation.
7Description
Colourless crystals, crystalline masses or blocks, or a white crystalline powder. It is odourless and has a sweet taste.
8Typical properties
- Melting point
- about 160–186 °C, with decomposition
- Solubility
- very soluble in water (about 1 in 0.5 at 20 °C); slightly soluble in ethanol; practically insoluble in chloroform and ether
- Specific rotation
- +66.3° to +67.0° (aqueous solution)
- True density
- ≈ 1.6 g/cm³
- Iso-osmotic concentration
- ≈ 9.25% w/v
9Stability and storage conditions
Stable at room temperature and moderate humidity. It can take up about 1% of moisture, which is released on heating to about 90 °C, and it caramelises above about 160 °C. In dilute acid, especially when heated, it is hydrolysed (inverted) to glucose and fructose; dilute aqueous solutions are also prone to fermentation. Store in a well-closed container in a cool, dry place.
10Incompatibilities
Trace heavy metals in powdered sucrose can cause incompatibility with some actives, such as ascorbic acid. The invert sugar formed by hydrolysis is reducing and can take part in Maillard browning with amines. Sucrose may also contain traces of sulfite from refining.
11Method of manufacture
Obtained from sugar cane or sugar beet. The juice is extracted, clarified with lime, concentrated by evaporation and crystallised; the raw sugar is separated by centrifugation and refined by redissolving, decolourising and recrystallising.
12Safety
Hydrolysed in the gut to glucose and fructose, which are absorbed. Regular use of sucrose-containing medicines promotes dental caries, and its sugar and energy content must be considered in diabetic patients and in large or chronic doses. It should be avoided in hereditary fructose intolerance, glucose–galactose malabsorption and sucrase–isomaltase deficiency.
13Handling precautions
Observe normal precautions for the quantity handled. Fine sugar dust can form explosive mixtures with air; avoid generating dust and sources of ignition.
14Regulatory status
GRAS listed. Included in the FDA Inactive Ingredient Database (oral and some parenteral preparations, among others) and in parenteral and non-parenteral medicines licensed in Europe, where label warnings apply to patients with sugar intolerances.
15Related substances
Compressible sugar; confectioner's sugar; invert sugar; liquid glucose; sugar spheres.
16Comments
Concentrated syrups are hostile to microbial growth because of their low water activity, but dilution, for example by water condensing on the surface of a stored syrup, can allow fermentation. Sucrose is a common lyoprotectant for proteins because it remains amorphous and forms a glassy matrix on freeze-drying.